FDA Drug Approvals
Printable Version   Email to a friend

Xibrom ISTA Pharmaceuticals, Inc. - Treatment for Ocular Inflammation Following Cataract Surgery

Xibrom is a sterile, topical, twice-daily, non-steroidal anti-inflammatory (NSAID) solution for the treatment of ocular inflammation following cataract surgery.

Related Articles:

Xibrom - ISTA Pharmaceuticals, Inc. - New Indication Approved - January 27, 2006

FDA Accepts ISTA Pharmaceuticals' New Drug Application for Xibrom - July 26, 2004

ISTA Pharmaceuticals Announces Submission of Xibrom NDA to the FDA - May 25, 2004

Latest FDA Drug Approvals...

FDA Drug Approvals Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Oct | Dec

More News Resources


MedNotes
Advertisement